MENU
+Compare
ACLX
Stock ticker: NASDAQ
AS OF
Jan 22, 12:49 PM (EDT)
Price
$64.55
Change
-$2.02 (-3.03%)
Capitalization
3.6B

ACLX Arcellx Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ACLX with price predictions
Jan 08, 2025

ACLX sees MACD Histogram crosses below signal line

ACLX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 08, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 25 instances where the indicator turned negative. In of the 25 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ACLX as a result. In of 60 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACLX advanced for three days, in of 176 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.452) is normal, around the industry mean (15.017). P/E Ratio (0.000) is within average values for comparable stocks, (88.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.838). ACLX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (22.321) is also within normal values, averaging (265.166).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ACLX is expected to report earnings to rise 15.96% to -55 cents per share on March 20

Arcellx ACLX Stock Earnings Reports
Q4'24
Est.
$-0.56
Q3'24
Missed
by $0.14
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.37
Q4'23
Beat
by $0.95
The last earnings report on November 08 showed earnings per share of -47 cents, missing the estimate of -34 cents. With 92.08K shares outstanding, the current market capitalization sits at 3.60B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
130
Web
https://www.arcellx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSNGX21.690.38
+1.78%
Loomis Sayles Global Growth N
DTGCX31.920.55
+1.75%
BNY Mellon Technology Growth C
WCEYX21.070.25
+1.20%
Macquarie Core Equity Fund Class Y
MPEGX23.060.27
+1.18%
Morgan Stanley Inst Discovery I
RIBEX59.340.67
+1.14%
American Funds Invmt Co of Amer R2E

ACLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.14%
DNLI - ACLX
49%
Loosely correlated
+5.06%
KYMR - ACLX
47%
Loosely correlated
+7.61%
RCKT - ACLX
47%
Loosely correlated
-1.45%
RCUS - ACLX
46%
Loosely correlated
+0.78%
BEAM - ACLX
46%
Loosely correlated
+4.65%
More